Osteoporosis and the resulting fractures are major public health issues as the world population is ageing. Various therapies such as bisphosphonates, strontium ranelate and more recently denosumab are available. This clinical guide provides the evidence for the clinical use of selective estrogen modulators (SERMs) in the management of osteoporosis in postmenopausal women.Journal ArticleReviewSCOPUS: ar.jinfo:eu-repo/semantics/publishe
Albright was the first of many to show that loss of bone mass due to estrogen deficiency is an impor...
Compounds that can be described as selective estrogen receptor modulators SERMs have expanded dramat...
Pharmacological management of osteoporosis includes use of calcium with vitamin D, bisphosphonates, ...
Osteoporosis and the resulting fractures are major public health issues as the world population is a...
Luigi Gennari, Daniela Merlotti, Ranuccio NutiDepartment of Internal Medicine, Endocrine-Metabolic S...
Selective estrogen receptor modulators (SERMs) are structurally different compounds that interact wi...
Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrog...
Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrog...
SUMMARY Selective estrogen receptor modulators (SERMs) have the ability to bind the estrogen recepto...
Osteoporosis is most prevalent in women over the age of 50 as the hormonal influence of estrogen on ...
Vaginal atrophy is common in postmenopausal women. This clinical guide provides the evidence for the...
peer reviewedLasofoxifene, a new selective estrogen receptor modulator (SERM), was investigated to a...
Osteoporosis is characterized by reduced bone mass and disruption of bone architecture, resulting in...
OBJECTIVE: The objective is to provide an update of the 2019 Pharmacological Management of Osteoporo...
For many years, significant research was being conducted on the effects of selective estrogen recept...
Albright was the first of many to show that loss of bone mass due to estrogen deficiency is an impor...
Compounds that can be described as selective estrogen receptor modulators SERMs have expanded dramat...
Pharmacological management of osteoporosis includes use of calcium with vitamin D, bisphosphonates, ...
Osteoporosis and the resulting fractures are major public health issues as the world population is a...
Luigi Gennari, Daniela Merlotti, Ranuccio NutiDepartment of Internal Medicine, Endocrine-Metabolic S...
Selective estrogen receptor modulators (SERMs) are structurally different compounds that interact wi...
Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrog...
Aromatase inhibitors (AIs) are the first-line recommended standard of care for postmenopausal estrog...
SUMMARY Selective estrogen receptor modulators (SERMs) have the ability to bind the estrogen recepto...
Osteoporosis is most prevalent in women over the age of 50 as the hormonal influence of estrogen on ...
Vaginal atrophy is common in postmenopausal women. This clinical guide provides the evidence for the...
peer reviewedLasofoxifene, a new selective estrogen receptor modulator (SERM), was investigated to a...
Osteoporosis is characterized by reduced bone mass and disruption of bone architecture, resulting in...
OBJECTIVE: The objective is to provide an update of the 2019 Pharmacological Management of Osteoporo...
For many years, significant research was being conducted on the effects of selective estrogen recept...
Albright was the first of many to show that loss of bone mass due to estrogen deficiency is an impor...
Compounds that can be described as selective estrogen receptor modulators SERMs have expanded dramat...
Pharmacological management of osteoporosis includes use of calcium with vitamin D, bisphosphonates, ...